OpenAI and Anthropic Move Toward IPOs, Accelerating AI in Healthcare

According to media reports, leading AI companies OpenAI and Anthropic have recently taken formal steps toward initial public offerings (IPOs), while both continue to expand their AI tool deployment in the healthcare sector. This move could draw greater investor interest in AI firms that are increasingly penetrating areas such as clinical workflows and life sciences. Notably, Anthropic confidentially filed a draft S-1 registration statement with the U.S. Securities and Exchange Commission (SEC) a week ago, planning to proceed with a public offering of common stock. Meanwhile, OpenAI CEO Sam Altman recently told employees that OpenAI expects to go public within the next year, with a target valuation of up to $1 trillion.

For the healthcare industry, the potential IPOs of these two AI giants offer a clearer view of how they are commercializing AI tools within regulated markets. These markets include hospitals, health systems, payers, clinicians, and pharmaceutical companies. Earlier, health-tracking ring maker Oura also filed for a confidential IPO in May, reinforcing the capital market trend in digital health. The IPO moves from OpenAI and Anthropic could set industry benchmarks for valuation and monetization models in medical AI.

Editor's Note: As generative AI accelerates its deployment in areas like medical imaging, drug discovery, and clinical decision support, capital market interest in the AI healthcare track is shifting from concept to substance. IPOs not only help ease the heavy R&D spending pressure for these two companies but also push them to disclose more detailed revenue structures and compliance costs, driving the industry toward greater transparency and standardization.